INvestigation on Routine Follow-up in CONgestive HearT FAilure Patients With Remotely Monitored Implanted Cardioverter Defibrillators (ICD) SysTems
NCT ID: NCT01200381
Last Updated: 2019-02-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
210 participants
INTERVENTIONAL
2010-02-28
2014-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The personal follow up (in clinic or phone calls) will be compared to completely automatic remote follow ups.
All patients will receive remote monitoring for automatic daily alarm checks and will undergo in clinic follow ups in 12 months intervals
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Resynchronization/Defibrillation for Ambulatory Heart Failure Trial
NCT00251251
Influence of Home Monitoring on the Clinical Status of Heart Failure Patients With an Impaired Left Ventricular Function
NCT00538356
Full Automaticity and Remote Follow-up
NCT01526629
REmote Web Assisted Care for Heart Failure Patients With Implantable Cardioverter Defibrillators
NCT01589913
Resynchronization/Defibrillation for Ambulatory Heart Failure Trial in Patients With Permanent Atrial Fibrillation
NCT01994252
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group A
Automatic anonymous ICD/CRTD follow up (quarterly remote follow ups)
Quarterly remote follow ups and remote monitoring
Quarterly remote follow ups and remote monitoring
Group B1
Personal ICD/CRTD follow up (phone calls + quarterly remote follow ups)
Quarterly remote follow ups + additional phone calls and remote monitoring
Quarterly remote follow ups + additional phone calls and remote monitoring
Group B2
Personal ICD/CRTD follow up (Quarterly visits)
Quarterly in clinic follow ups and remote monitoring
Quarterly in clinic follow ups and remote monitoring
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Quarterly remote follow ups and remote monitoring
Quarterly remote follow ups and remote monitoring
Quarterly remote follow ups + additional phone calls and remote monitoring
Quarterly remote follow ups + additional phone calls and remote monitoring
Quarterly in clinic follow ups and remote monitoring
Quarterly in clinic follow ups and remote monitoring
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Written informed consent
* Ejection Fraction \<= 35%
* New York Heart Association (NYHA) Class I-III
* Age \>=18 and \<=80 years
* In patient's home environment sufficient infrastructure (analog phone line or sufficient strength of GSM (Global System for Mobile communication) mobile phone network) for running a Merlin@home transmitter is available
Exclusion Criteria
* Severe renal insufficiency
* Coronary angiology intervention within previous 3 months
* Myocardial infarction within previous month
* Life expectancy \< 1 year
* Expected poor data quality / compliance
* Pregnancy
* Patient is already participating to another study with active therapy arm
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Abbott Medical Devices
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Christian Weiss, Prof. Dr. med.
Role: STUDY_CHAIR
Städtisches Klinikum Lüneburg gGmbH
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
SLK-Kliniken Heilbronn GmbH Klinikum am Plattenwald
Bad Friedrichshall, , Germany
Asklepios Klinik Bad Oldesloe
Bad Oldesloe, , Germany
Segeberger Kliniken GmbH
Bad Segeberg, , Germany
Evangelisches Krankenhaus Bielefeld gGmbH
Bielefeld, , Germany
Evangelisches Krankenhaus Kalk
Cologne, , Germany
Universitätsklinikum Essen (AöR)
Essen, , Germany
Herzkatheterlabor der Kardiologischen Praxis am Krankenhaus Neu-Bethlehem gGmbH
Göttingen, , Germany
Asklepios Klinik St. Georg
Hamburg, , Germany
Asklepios Klinik Barmbek
Hamburg, , Germany
Klinikum Ingolstadt GmbH
Ingolstadt, , Germany
Kardiologische Praxis - Partnergesellschaft
Ludwigsburg, , Germany
Städtisches Klinikum Lüneburg gGmbH
Lüneburg, , Germany
Marienhaus Klinikum St. Elisabeth-Krankenhaus
Neuwied, , Germany
Praxis Dr. med. Balbach / Ruppert
Nürtingen, , Germany
Kardiologische Gemeinschaftspraxis am Park Sanssouci
Potsdam, , Germany
Klinikum Sindelfingen-Böblingen gGmbH
Sindelfingen, , Germany
Marienhospital Stuttgart
Stuttgart, , Germany
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Hansen C, Loges C, Seidl K, Eberhardt F, Troster H, Petrov K, Gronefeld G, Bramlage P, Birkenhauer F, Weiss C. INvestigation on Routine Follow-up in CONgestive HearT FAilure Patients with Remotely Monitored Implanted Cardioverter Defibrillators SysTems (InContact). BMC Cardiovasc Disord. 2018 Jun 28;18(1):131. doi: 10.1186/s12872-018-0864-7.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
T94
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.